Buradasınız

Antihyperglycaemic and Antihyperproteinaemic Activity of Extracts of Picralima nitida Seed and Tapinanthus bangwensis Leaf on Alloxan-Induced Diabetic Rabbits

Journal Name:

Publication Year:

Abstract (2. Language): 
Coconut water extract of Picralima nitida seed and aqueous extract of Tapinanthus bangwensis leaf were investigated for their antidiabetic activities on some biochemical parameters (glucose, protein) associated with diabetes in both the serum and tissues of experimental animals using alloxan-induced diabetic rabbits as model. The rabbits were fasted overnight before they were given a single intraperitoneal injection of aqueous alloxan monohydrate (Sigma, USA) at a dose of 300 mg/kg body weight to make them diabetic. The experimental rabbits (chinchilla) were grouped into six and extracts administered orally, once daily for five weeks. Groups 1 and 2 (non-diabetic) received only distilled water and coconut water respectively, group 3 (diabetic) received 200 mg/kg body weight aqueous extract of T. bangwensis leaf, group 4 received 400 mg/kg body weight of coconut water extract of P. nitida seed, groups 5 and 6 (diabetic) received only distilled water and coconut water respectively. The results revealed that the extracts independently lowered significantly (p<0.05) the blood glucose and protein levels of the diabetic rabbits. Both extracts significantly (p<0.05) increased the tissue protein. Overall, aqueous extract of T. bangwensis leaf and coconut water extract of P. nitida seed independently possesses insulin-like properties as demonstrated by their antidiabetic actions, hence, may be good herbal extracts in the management of diabetes.
FULL TEXT (PDF): 
1125-1131

REFERENCES

References: 

[1] L. M. Tierney, S. J. McPhee, and M. A. Papadakis, Current Medical Diagnosis and Treatment, International edition. New
York: Lange Medical Books, McGraw-Hill, 2002.
[2] NHANES, National Health and Nutrition Examination Survey 2002-2009, India, 2009.
[3] World Health Organization, World Health Statistics 2011: Facts and Figures about Diabetes, WHO Statistical Information
System, 2011.
[4] World Health Organization, Report of The WHO Expert Committee on Diabetes Mellitus, Technical Report Series 646,
Geneva, vol. 66, 2000.
[5] E. O. Olapade, “Modern Ethnomedicine in Diabetes Mellitus,” Natural Cure Series, 2: 120, 1995.
[6] A. M. Gray, and P. R. Flatt, “Insulin-Secreting Activity of the Traditional Antidiabetic Plant Viscum album (Mistletoe)”,
Journal of Endocrinolog, vol. 160, pp. 409–414, 1999.
[7] S. Lenzen, “The Mechanisms of Alloxan and Streptozotocin-Induced Diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226,
2008.
[8] P. E. Lacy and M. Kostianosvky, “Method for the Isolation of Intact Islets of Langarhans from the Rat Pancreas,”
Diabetes, vol. 16, pp. 35-39, 1963.
[9] A. A. Adesokan, O. I. Oyewole, and B. M. S. Turay, “Kidney and Liver Function Parameters in Alloxan-Induced Diabetic
Rats Treated with Aloe barbadensis Juice Extract”, Sierra Leone J Biomed Res., vol. 1, no. 1, pp. 33-37, 2009.
[10] A. C Gornal, C. J. Bardwell, and M. M. David, “Determination of Serum Protein by Means of Biuret Reaction”, J. Biol.
Chem., vol. 177 pp. 751-756, 1949.
[11] R. G. D. Steel, and J. H. Torrie, Principles and Procedures of Statistics: A Biometric Approach, 2nd ed., McGraw Hill Books
Co., New York, USA, 1980.
[12] S. S. Gyang, D. D. Nyam, and E. N. Sokomba, “Hypoglycaemic Activity of Vernonia amygdalina (Chloroform extract) in
Normoglycaemic and Alloxan-Induced Hyperglycaemic Rats,” J. Pharm. Bioresources, vol. 1, no. 1, pp. 61-66, 2004.
[13] J. S. Kim, J. B. Ju, C. W. Choi, and S. C. Kim, “Hypoglycaemic and Antihyperglycaemic Effect of Four Korean Medicinal
Plants in Alloxan Induced Diabetc Rats,” Am. J. Biochem. Biotech., vol. 2, no. 4, pp. 154-160, 2006.
[14] P. E. Ebong, I. J. Tangwho, E. U. Eyong, C. Ukwe, and A. U. Obi, “Pancreatic Beta Cell Regeneration: A Probable Parallel
Mechanism of Hypoglycemic Action of Vernonia amygdalina Del. and Azadirachta indica”, In the Proceeding of the 2006
International Neem Conference, pp. 83-89, 2006.
[15] T. M. Delvin, Textbook of Biochemistry with Clinical Correlations, Sixth Edition. John Wiley & Sons, Inc. Publications,
2006.
[16] A. E. Eno, and E. H. Itam, “Hypoglycaemic agents in leaves of Eleophorbia drupifera”, Phytother. Res., vol. 10, pp. 680-
682, 1996.
[17] O. A. Akinloye, and B. R. Olorode, “Effect of Amaranthus spinosa Leaf Extract on Haematology and Serum Chemistry of
Rats”, Nigerian J. Nat. Prod. Med., vol. 4, pp. 79-81, 2000.
[18] S. K. Swanston-Flatt, C. Day, C. J. Bailey, and P. R. Flatt, “Evaluation of Traditional Plant Treatments for Diabetes: Studies
in Streptozotocin Diabetic Mice,” Acta Diabetologica Latin, vol. 26, pp. 51–55, 1989.
[19] C. N. Aguwa, C. V. Ukwe, S. I. Inya-Agha, and J. M. Okonta, “Antidiabetic Effect of Picralima nitida Aqueous Seed Extract
in Experimental Rabbit Model,” J. Nat. Remedies, vol. 1, no. 2, pp. 135–139, 2001.
Bosede M. Adegoke and Oyelola B. Oloyede
ISSN : 2028-9324 Vol. 3 No. 4, Aug. 2013 1131
[20] A. K. Tiwari, and J. M. Rao, “Diabetes Mellitus and Multiple Therapeutic Approaches of Phytochemicals: Present Status
and Future Prospects,” Curr. Sci., vol. 83, no. 1, pp. 30-37, 2002.
[21] KI Rother, “Diabetes Treatment — Bridging the Divide,” N Engl J Med, vol. 356, no. 15, pp. 1499–1501, 2007.
[22] N. J. Morrish, L. K. Stevens, J. H. Fuller, H. Keen, and R. J. Jerret, “Incidence of Microvascular Diseases in Diabetes
Mellitus: The London Cohort of the WHO Multinational Study of Vascular Diseases in Diabetes,” Diabetologia, vol. 34,
pp. 534-589, 1999.
[23] F. G. William, Review of Medical Pharmacology, Mc Graw Hill, 20th Edition, 1999.
[24] L. Andrew, and J. Goslin, “Microalbuminuria: Yet Another Cardiovascular Risk Factor?,” Ann. Clin. Biochem., vol. 36, pp.
700-703, 1999.
[25] P. Zimmet, G. Dowse and C. Finch, “Epidemiology and Natural History of NIDDM- Lessions from the Pacific,” Dialmet
Rev., vol. 12, pp. 121-134, 1996.

Thank you for copying data from http://www.arastirmax.com